ArticleThe International journal on drug policy2022

Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020.

Paxton Bach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.